Australian Clinical Labs Ltd (AU:ACL) has released an update.
Morgan Stanley and its subsidiaries have ceased to be substantial shareholders in Australian Clinical Labs Limited as of September 17, 2024. They reported a series of transactions involving the buying and selling of the company’s ordinary shares on the same day. The changes in shareholding were reported to Australian Clinical Labs Limited shortly after they occurred.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.